Potential role for tissue factor in the pathogenesis of hypercoagulability associated with in COVID-19 Mario Bautista-VargasFabio Bonilla-AbadíaCarlos A. Cañas ReviewPaper 09 June 2020 Pages: 479 - 483
Detailed thrombogenicity phenotyping and 1 year outcomes in patients undergoing WATCHMAN implantation: (TARGET-WATCHMAN) a case–control study Matthew SherwoodKevin P. BlidenPaul A. Gurbel OriginalPaper 29 June 2020 Pages: 484 - 498
COVID-19-associated vasculitis and vasculopathy Richard C. Becker Editorial 22 July 2020 Pages: 499 - 511
Anticipating the long-term cardiovascular effects of COVID-19 Richard C. Becker Editorial 03 September 2020 Pages: 512 - 524
Platelet factor 4 and β-thromboglobulin mRNAs in circulating microparticles of trauma patients as diagnostic markers for deep vein thrombosis Yu SuYuying ChenJun Wu OriginalPaper 28 April 2020 Pages: 525 - 532
Cardiomyocyte microvesicles: proinflammatory mediators after myocardial ischemia? Patrick Malcolm SiegelJudith SchmichPhilipp Diehl OriginalPaper Open access 14 June 2020 Pages: 533 - 542
Incidence and consequences of systemic arterial thrombotic events in COVID-19 patients Estefanía CantadorAlberto NúñezJavier Botas BriefCommunication 09 June 2020 Pages: 543 - 547
Evaluation of variation in D-dimer levels among COVID-19 and bacterial pneumonia: a retrospective analysis Bilian YuXin LiJianjun Tang OriginalPaper 10 June 2020 Pages: 548 - 557
Rate of venous thromboembolism in a prospective all-comers cohort with COVID-19 Marina RiederIsabella GollerAchim Lother OriginalPaper Open access 02 July 2020 Pages: 558 - 566
COVID-19: Are we dealing with a multisystem vasculopathy in disguise of a viral infection? Ritwick MondalDurjoy LahiriSubhash C. Biswas ReviewPaper 05 July 2020 Pages: 567 - 579
Profile of natural anticoagulant, coagulant factor and anti-phospholipid antibody in critically ill COVID-19 patients Yan ZhangWei CaoTienan Zhu OriginalPaper 09 July 2020 Pages: 580 - 586
COVID-19 and ischemic stroke: a systematic review and meta-summary of the literature Ying-Kiat TanClaire GohBenjamin Y. Q. Tan OriginalPaper 13 July 2020 Pages: 587 - 595
Impact of the COVID-19 pandemic on hyperacute stroke treatment: experience from a comprehensive stroke centre in Singapore Prakash R. PaliwalBenjamin Y. Q. TanBernard P. L. Chan OriginalPaper 13 July 2020 Pages: 596 - 603
Ovarian vein thrombosis after coronavirus disease (COVID-19) infection in a pregnant woman: case report Susan MohammadiMorteza AbouzaripourMohammad Bakhtiar Hesam Shariati Report 08 June 2020 Pages: 604 - 607
Clinical features and efficacy of reperfusion therapy in minor ischemic stroke patients with atrial fibrillation Eiichi NomuraMakoto TakemaruShinzo Ota OriginalPaper 11 February 2020 Pages: 608 - 613
The SAMe–TT2R2 score as an indicator of warfarin control for patients with deep vein thrombosis in Queensland, Australia Nijole BernaitisTony BadrickShailendra Anoopkumar-Dukie BriefCommunication 20 February 2020 Pages: 614 - 618
Intensified P2Y12 inhibition for high-on treatment platelet reactivity Fakilahyel S. MshelbwalaDaniel W. HugenbergRolf P. Kreutz OriginalPaper 09 March 2020 Pages: 619 - 627
Evaluation of a rapid turn-over, fully-automated ADAMTS13 activity assay: a method comparison study Jan StratmannJosephine-Nana WardWolfgang Miesbach BriefCommunication Open access 26 March 2020 Pages: 628 - 631
Point-of-care testing of coagulation in patients treated with edoxaban Florian HärtigIngvild BirschmannSven Poli OriginalPaper Open access 20 May 2020 Pages: 632 - 639
Cardiovascular risk factor in MPN patients Vincenzo AccursoMarco SantoroSergio Siragusa Letter to the Editor 30 January 2020 Pages: 640 - 641
Are direct oral anticoagulants an economically attractive alternative to low molecular weight heparins in lung cancer associated venous thromboembolism management? Jennifer HowlettEric BenzenineCatherine Quantin OriginalPaper 04 February 2020 Pages: 642 - 651
Portal vein thrombosis patients harboring JAK2V617F have poor long-term outcomes despite anticoagulation Leonard NaymagonDouglas TremblayJohn Mascarenhas OriginalPaper 07 February 2020 Pages: 652 - 660
DOAC compared to LMWH in the treatment of cancer related-venous thromboembolism: a systematic review and meta-analysis V. MaiV. F. TanguayS. Provencher BriefCommunication 12 February 2020 Pages: 661 - 667
Left atrial appendage closure: a balanced management of the thromboembolic risk in patients with hemophilia and atrial fibrillation Marco ToselliDavide BosiLuigi Vignali BriefCommunication 08 April 2020 Pages: 668 - 673
Persisting autoimmune heparin-induced thrombocytopenia after elective abdominal aortic aneurysm repair: a case report Guillaume RobergeTobias TritschlerDimitrios Scarvelis BriefCommunication 13 February 2020 Pages: 674 - 677
Identification and characterization of a novel variant in C-terminal region of Antithrombin (Ala427Thr) associated with type II AT deficiency leading to polymer formation Teena BhakuniAmit SharmaMohamad Aman Jairajpuri OriginalPaper 04 February 2020 Pages: 678 - 685
Factor XIII deficiency in two Spanish families with a novel variant in gene F13A1 detected by next-generation sequencing; symptoms and clinical management Andrés MoretÁngel ZúñigaSantiago Bonanad BriefCommunication 15 February 2020 Pages: 686 - 688
Anemone study: prevalence of risk factors for superficial vein thrombosis in a large Italian population of blood donors Elvira GrandoneGiovanni Luca TisciaFCSA (Italian Federation of Anticoagulation Clinics) OriginalPaper 20 May 2020 Pages: 689 - 696
Barriers and facilitators to optimal oral anticoagulant management: a scoping review Mei WangAnne HolbrookLehana Thabane ReviewPaper 10 February 2020 Pages: 697 - 714
Implementation and impact of a multidisciplinary coagulation factor stewardship program at an academic medical center Anem WaheedJustin FongemieRaymond L. Comenzo Letter to the Editor 27 February 2020 Pages: 715 - 717
Satisfaction, quality of life and therapy adherence assessment in real life patients transitioning from vitamin K antagonists to direct oral anticoagulants Alessandra SerraoBenedetta LucaniAntonio Chistolini BriefCommunication 28 February 2020 Pages: 718 - 723
Comparing the efficacy and safety of direct oral anticoagulants with vitamin K antagonist in cerebral venous thrombosis Grace K. H. LeeVanessa H. ChenBenjamin Y. Q. Tan OriginalPaper 11 April 2020 Pages: 724 - 731
The management of patients with acute ischemic stroke while on direct oral anticoagulants (DOACs): data from an Italian cohort and a proposed algorithm E. RotaL. TestaN. Morelli BriefCommunication 17 April 2020 Pages: 732 - 738
The role of clinical pharmacy anticoagulation services in direct oral anticoagulant monitoring Aubrey E. JonesJordan B. KingDaniel M. Witt OriginalPaper 21 February 2020 Pages: 739 - 745
National trends in tranexamic acid use in the peripartum period, 2015–2019 Homa K. AhmadziaElaine B. HyndsNaomi L. C. Luban OriginalPaper 25 May 2020 Pages: 746 - 752
Heart failure patients have enhanced cerebral autoregulation response in acute ischemic stroke Pedro CastroJorge SerradorElsa Azevedo OriginalPaper 01 June 2020 Pages: 753 - 761